Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03582475
Brief Title: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate

First Submitted : June 13, 2018
First Submitted that Met QC Criteria : July 9, 2018
First Posted : July 11, 2018

Last Update Submitted that Met QC Criteria : July 12, 2021
Last Update Posted : July 14, 2021